Table 3 Gene set enrichment analysis results using Ingenuity Pathway Analysis (IPA)
Term | Geneset | # Of genes | p-value(s): UL, LL |
|---|---|---|---|
Diseases & Disorders | |||
CNS tumor related | Tissue | 38 | 4.6e−05, 0.006 |
Serum | 26 | 0.0028, 0.0155 | |
Cancer | Serum | 36 | 0.0012, 0.0175 |
Tumor development | Tissue | 36 | 7.6e−05, 0.0012 |
Meningioma-related | Serum | 5 | 1.47e−04, 0.011 |
MN-1 related | Tissue | 1 | 0.0135 |
Molecular and cellular functions | |||
Immune Response | Serum | 21 | 4.85e−04, 0.0178 |
Tissue | 1 | 0.00678 | |
Cell growth/proliferation | Tissue | 19 | 2.32e−04, 0.0284 |
Serum | 9 | 5.47e−04, 0.0145 | |
Cellular movement | Tissue | 17 | 5.31e−04, 0.0269 |
Serum | 14 | 0.0047, 0.0179 | |
Cell assembly | Tissue | 15 | 1.74e−04, 0.0282 |
Serum | 5 | 0.0011, 0.0163 | |
Cell death | Tissue | 15 | 0.0034, 0.0227 |
Serum | 12 | 0.0011, 0.0145 | |
Embryonic development | Tissue | 13 | 0.0022, 0.0132 |
Cell cycle | Serum | 13 | 0.0018, 0.0163 |
Tissue | 7 | 1.26e−04, 0.0285 | |
CNS development | Serum | 11 | 0.0017, 0.0018 |
Cell-to-cell signaling | Tissue | 10 | 0.0017, 0.0269 |
Serum | 10 | 4.56e−04, 0.0163 | |
Cell function | Serum | 6 | 0.0018, 0.0181 |
Cell-mediated immune response | Tissue | 3 | 0.0034, 0.0285 |
Cell development | Serum | 3 | 0.0012, 0.0018 |
